Clinical study to evaluate the safety and efficacy of Herbal formulation for Obesity [HFO-O2] in overweight individuals

Baidyanath Bhavan Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

研究概览

暂无简介。

•1.Overweight individuals (Body Mass Index between 25-30) with controlled co-morbid dyslipidemia and/or hypertension and/or type 1 or type 2 diabetes
•2.Stable body weight (less than 5 kg self-reported change during the previous 3 months)
•3.Age between 18 years and 60 years
•4.Individuals found compliant based on the Million Behavioural Medicine Diagnostic (MBMD)
•5.Willing to give Informed consent before any trial-related activity takes place

•1.Known case of endocrinological disorders such as hyper/hypo thyroidism, Poly Cystic Ovarian Syndrome (PCOS)
•2.History of use one month before screening /currently using Allopathic or Ayurvedic medicines that may cause significant weight gain
•3.History of use one month before screening /currently using dietary supplements, over-the-counter medications or below mentioned Allopathic /Ayurvedic medicines for weight loss
•4.Current participation (past one month) in an organized weight reduction program
•5.Participants with a history of major depressive or other severe psychiatric disorders or an eating disorder [judged by frequency and quantity of food]
•6.Surgery scheduled for the trial duration period, except for minor surgical procedures, at the discretion of the investigator
•7.Pregnant or lactating females

发起方

Baidyanath Bhavan Pvt Ltd